APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Long-Term Asthma Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Long-Term Asthma Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174008910331 December 2025182 pages

Choose your research edition.

Industry ResearchLong-Term Asthma Drugs Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-Term Asthma Drugs Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Long-Term Asthma Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-Term Asthma Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-Term Asthma Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Long-Term Asthma Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Long-Term Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Long-Term Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Long-Term Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Long-Term Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Long-Term Asthma Drugs include Novartis, Merck, Roche, Pfizer, GlaxoSmithKline, AstraZeneca, Vectura Group, Teva Pharmaceutical and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Long-Term Asthma Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Long-Term Asthma Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Long-Term Asthma Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Long-Term Asthma Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Long-Term Asthma Drugs Segment by Company

Novartis

Merck

Roche

Pfizer

GlaxoSmithKline

AstraZeneca

Vectura Group

Teva Pharmaceutical

Boehringer Ingelheim

Long-Term Asthma Drugs Segment by Type

Tablet

Spray

Long-Term Asthma Drugs Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Long-Term Asthma Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-Term Asthma Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-Term Asthma Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-Term Asthma Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Long-Term Asthma Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Long-Term Asthma Drugs industry.

Chapter 3: Detailed analysis of Long-Term Asthma Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Long-Term Asthma Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Long-Term Asthma Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Tablet Table 3. Key Players of Spray Table 4. Global Long-Term Asthma Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Retail Pharmacy Table 6. Key Players of Online Pharmacy Table 7. Key Players of Hospital Pharmacy Table 8. Global Long-Term Asthma Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Long-Term Asthma Drugs Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Long-Term Asthma Drugs Market Share by Region (2021-2026) Table 11. Global Long-Term Asthma Drugs Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Long-Term Asthma Drugs Market Share by Region (2027-2032) Table 13. Long-Term Asthma Drugs Industry Trends Table 14. Long-Term Asthma Drugs Industry Drivers Table 15. Long-Term Asthma Drugs Industry Opportunities and Challenges Table 16. Long-Term Asthma Drugs Industry Restraints Table 17. Global Long-Term Asthma Drugs Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Long-Term Asthma Drugs Revenue Market Share by Company (2021-2026) Table 19. Global Long-Term Asthma Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Long-Term Asthma Drugs Key Company Head Office and Area Served Table 21. Global Long-Term Asthma Drugs Company, Product Type & Application Table 22. Global Long-Term Asthma Drugs Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Long-Term Asthma Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Long-Term Asthma Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Long-Term Asthma Drugs Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Long-Term Asthma Drugs Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Long-Term Asthma Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Long-Term Asthma Drugs Revenue Market Share by Type (2027-2032) Table 30. Global Long-Term Asthma Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Long-Term Asthma Drugs Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Long-Term Asthma Drugs Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Long-Term Asthma Drugs Revenue Market Share by Application (2021-2026) Table 34. Global Long-Term Asthma Drugs Revenue Market Share by Application (2027-2032) Table 35. Novartis Company Information Table 36. Novartis Business Overview Table 37. Novartis Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Novartis Long-Term Asthma Drugs Product Portfolio Table 39. Novartis Recent Development Table 40. Merck Company Information Table 41. Merck Business Overview Table 42. Merck Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Merck Long-Term Asthma Drugs Product Portfolio Table 44. Merck Recent Development Table 45. Roche Company Information Table 46. Roche Business Overview Table 47. Roche Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Roche Long-Term Asthma Drugs Product Portfolio Table 49. Roche Recent Development Table 50. Pfizer Company Information Table 51. Pfizer Business Overview Table 52. Pfizer Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Pfizer Long-Term Asthma Drugs Product Portfolio Table 54. Pfizer Recent Development Table 55. GlaxoSmithKline Company Information Table 56. GlaxoSmithKline Business Overview Table 57. GlaxoSmithKline Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. GlaxoSmithKline Long-Term Asthma Drugs Product Portfolio Table 59. GlaxoSmithKline Recent Development Table 60. AstraZeneca Company Information Table 61. AstraZeneca Business Overview Table 62. AstraZeneca Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. AstraZeneca Long-Term Asthma Drugs Product Portfolio Table 64. AstraZeneca Recent Development Table 65. Vectura Group Company Information Table 66. Vectura Group Business Overview Table 67. Vectura Group Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Vectura Group Long-Term Asthma Drugs Product Portfolio Table 69. Vectura Group Recent Development Table 70. Teva Pharmaceutical Company Information Table 71. Teva Pharmaceutical Business Overview Table 72. Teva Pharmaceutical Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Teva Pharmaceutical Long-Term Asthma Drugs Product Portfolio Table 74. Teva Pharmaceutical Recent Development Table 75. Boehringer Ingelheim Company Information Table 76. Boehringer Ingelheim Business Overview Table 77. Boehringer Ingelheim Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Boehringer Ingelheim Long-Term Asthma Drugs Product Portfolio Table 79. Boehringer Ingelheim Recent Development Table 80. North America Long-Term Asthma Drugs Market Size by Type (2021-2026) & (US$ Million) Table 81. North America Long-Term Asthma Drugs Market Size by Type (2027-2032) & (US$ Million) Table 82. North America Long-Term Asthma Drugs Market Size by Application (2021-2026) & (US$ Million) Table 83. North America Long-Term Asthma Drugs Market Size by Application (2027-2032) & (US$ Million) Table 84. North America Long-Term Asthma Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Long-Term Asthma Drugs Market Size by Country (2021-2026) Table 86. North America Long-Term Asthma Drugs Market Size by Country (2027-2032) Table 87. Europe Long-Term Asthma Drugs Market Size by Type (2021-2026) & (US$ Million) Table 88. Europe Long-Term Asthma Drugs Market Size by Type (2027-2032) & (US$ Million) Table 89. Europe Long-Term Asthma Drugs Market Size by Application (2021-2026) & (US$ Million) Table 90. Europe Long-Term Asthma Drugs Market Size by Application (2027-2032) & (US$ Million) Table 91. Europe Long-Term Asthma Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe Long-Term Asthma Drugs Market Size by Country (2021-2026) Table 93. Europe Long-Term Asthma Drugs Market Size by Country (2027-2032) Table 94. China Long-Term Asthma Drugs Market Size by Type (2021-2026) & (US$ Million) Table 95. China Long-Term Asthma Drugs Market Size by Type (2027-2032) & (US$ Million) Table 96. China Long-Term Asthma Drugs Market Size by Application (2021-2026) & (US$ Million) Table 97. China Long-Term Asthma Drugs Market Size by Application (2027-2032) & (US$ Million) Table 98. Asia Long-Term Asthma Drugs Market Size by Type (2021-2026) & (US$ Million) Table 99. Asia Long-Term Asthma Drugs Market Size by Type (2027-2032) & (US$ Million) Table 100. Asia Long-Term Asthma Drugs Market Size by Application (2021-2026) & (US$ Million) Table 101. Asia Long-Term Asthma Drugs Market Size by Application (2027-2032) & (US$ Million) Table 102. Asia Long-Term Asthma Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia Long-Term Asthma Drugs Market Size by Country (2021-2026) Table 104. Asia Long-Term Asthma Drugs Market Size by Country (2027-2032) Table 105. South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Type (2021-2026) & (US$ Million) Table 106. South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Type (2027-2032) & (US$ Million) Table 107. South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Application (2021-2026) & (US$ Million) Table 108. South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Application (2027-2032) & (US$ Million) Table 109. South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Country (2021-2026) Table 111. South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Country (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Long-Term Asthma Drugs Product Image Figure 2. Global Long-Term Asthma Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Long-Term Asthma Drugs Market Share by Type: 2025 VS 2032 Figure 4. Tablet Image Figure 5. Spray Image Figure 6. Global Long-Term Asthma Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Long-Term Asthma Drugs Market Share by Application: 2025 VS 2032 Figure 8. Retail Pharmacy Image Figure 9. Online Pharmacy Image Figure 10. Hospital Pharmacy Image Figure 11. Global Long-Term Asthma Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 13. Global Long-Term Asthma Drugs Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Long-Term Asthma Drugs Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Long-Term Asthma Drugs Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Long-Term Asthma Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Long-Term Asthma Drugs Revenue Market Share by Type (2021-2032) Figure 20. Global Long-Term Asthma Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Long-Term Asthma Drugs Revenue Market Share by Application (2021-2032) Figure 22. North America Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 23. North America Long-Term Asthma Drugs Market Share by Type (2021-2032) Figure 24. North America Long-Term Asthma Drugs Market Share by Application (2021-2032) Figure 25. North America Long-Term Asthma Drugs Market Share by Country (2021-2032) Figure 26. United States Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 27. Canada Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 29. Europe Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 30. Europe Long-Term Asthma Drugs Market Share by Type (2021-2032) Figure 31. Europe Long-Term Asthma Drugs Market Share by Application (2021-2032) Figure 32. Europe Long-Term Asthma Drugs Market Share by Country (2021-2032) Figure 33. Germany Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 34. France Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 36. Italy Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 37. Russia Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 39. China Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 40. China Long-Term Asthma Drugs Market Share by Type (2021-2032) Figure 41. China Long-Term Asthma Drugs Market Share by Application (2021-2032) Figure 42. Asia Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 43. Asia Long-Term Asthma Drugs Market Share by Type (2021-2032) Figure 44. Asia Long-Term Asthma Drugs Market Share by Application (2021-2032) Figure 45. Asia Long-Term Asthma Drugs Market Share by Country (2021-2032) Figure 46. Japan Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 50. India Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 51. Australia Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Long-Term Asthma Drugs Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Long-Term Asthma Drugs Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Long-Term Asthma Drugs Market Share by Country (2021-2032) Figure 56. Brazil Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 61. UAE Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 63. Chile Long-Term Asthma Drugs Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Spray
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Vectura Group
  • Teva Pharmaceutical
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Long-Term Asthma Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Tablet
  5. 1.2.3 Spray
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Long-Term Asthma Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Retail Pharmacy
  9. 1.3.3 Online Pharmacy
  10. 1.3.4 Hospital Pharmacy
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Long-Term Asthma Drugs Growth Trends by Region
  13. 1.5.1 Global Long-Term Asthma Drugs Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Long-Term Asthma Drugs Market Size by Region (2021-2026)
  15. 1.5.3 Long-Term Asthma Drugs Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Long-Term Asthma Drugs Market Dynamics
  1. 2.1 Long-Term Asthma Drugs Industry Trends
  2. 2.2 Long-Term Asthma Drugs Industry Drivers
  3. 2.3 Long-Term Asthma Drugs Industry Opportunities and Challenges
  4. 2.4 Long-Term Asthma Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Long-Term Asthma Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Long-Term Asthma Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Long-Term Asthma Drugs Key Company Head office and Area Served
  4. 3.4 Global Long-Term Asthma Drugs Company, Product Type & Application
  5. 3.5 Global Long-Term Asthma Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Long-Term Asthma Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Long-Term Asthma Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Long-Term Asthma Drugs Tier 1, Tier 2, and Tier 3
4 Long-Term Asthma Drugs Market by Type
  1. 4.1 Global Long-Term Asthma Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Long-Term Asthma Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Long-Term Asthma Drugs Market Size Share by Type (2021-2032)
5 Long-Term Asthma Drugs Market by Application
  1. 5.1 Global Long-Term Asthma Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Long-Term Asthma Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Long-Term Asthma Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis Long-Term Asthma Drugs Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Merck Long-Term Asthma Drugs Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Roche Long-Term Asthma Drugs Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer Long-Term Asthma Drugs Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 GlaxoSmithKline Long-Term Asthma Drugs Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 AstraZeneca Long-Term Asthma Drugs Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Vectura Group
  38. 6.7.1 Vectura Group Company Information
  39. 6.7.2 Vectura Group Business Overview
  40. 6.7.3 Vectura Group Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Vectura Group Long-Term Asthma Drugs Product Portfolio
  42. 6.7.5 Vectura Group Recent Developments
  43. 6.8 Teva Pharmaceutical
  44. 6.8.1 Teva Pharmaceutical Company Information
  45. 6.8.2 Teva Pharmaceutical Business Overview
  46. 6.8.3 Teva Pharmaceutical Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Teva Pharmaceutical Long-Term Asthma Drugs Product Portfolio
  48. 6.8.5 Teva Pharmaceutical Recent Developments
  49. 6.9 Boehringer Ingelheim
  50. 6.9.1 Boehringer Ingelheim Company Information
  51. 6.9.2 Boehringer Ingelheim Business Overview
  52. 6.9.3 Boehringer Ingelheim Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Boehringer Ingelheim Long-Term Asthma Drugs Product Portfolio
  54. 6.9.5 Boehringer Ingelheim Recent Developments
7 North America
  1. 7.1 North America Long-Term Asthma Drugs Market Size (2021-2032)
  2. 7.2 North America Long-Term Asthma Drugs Market Size by Type
  3. 7.2.1 North America Long-Term Asthma Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Long-Term Asthma Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Long-Term Asthma Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Long-Term Asthma Drugs Market Size by Application
  7. 7.3.1 North America Long-Term Asthma Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Long-Term Asthma Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Long-Term Asthma Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Long-Term Asthma Drugs Market Size by Country
  11. 7.4.1 North America Long-Term Asthma Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Long-Term Asthma Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Long-Term Asthma Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Long-Term Asthma Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Long-Term Asthma Drugs Market Size (2021-2032)
  2. 8.2 Europe Long-Term Asthma Drugs Market Size by Type
  3. 8.2.1 Europe Long-Term Asthma Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Long-Term Asthma Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Long-Term Asthma Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Long-Term Asthma Drugs Market Size by Application
  7. 8.3.1 Europe Long-Term Asthma Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Long-Term Asthma Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Long-Term Asthma Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Long-Term Asthma Drugs Market Size by Country
  11. 8.4.1 Europe Long-Term Asthma Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Long-Term Asthma Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Long-Term Asthma Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Long-Term Asthma Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Long-Term Asthma Drugs Market Size (2021-2032)
  2. 9.2 China Long-Term Asthma Drugs Market Size by Type
  3. 9.2.1 China Long-Term Asthma Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Long-Term Asthma Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Long-Term Asthma Drugs Market Share by Type (2021-2032)
  6. 9.3 China Long-Term Asthma Drugs Market Size by Application
  7. 9.3.1 China Long-Term Asthma Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Long-Term Asthma Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Long-Term Asthma Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Long-Term Asthma Drugs Market Size (2021-2032)
  2. 10.2 Asia Long-Term Asthma Drugs Market Size by Type
  3. 10.2.1 Asia Long-Term Asthma Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Long-Term Asthma Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Long-Term Asthma Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Long-Term Asthma Drugs Market Size by Application
  7. 10.3.1 Asia Long-Term Asthma Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Long-Term Asthma Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Long-Term Asthma Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Long-Term Asthma Drugs Market Size by Country
  11. 10.4.1 Asia Long-Term Asthma Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Long-Term Asthma Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Long-Term Asthma Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Long-Term Asthma Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Long-Term Asthma Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Long-Term Asthma Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Long-Term Asthma Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Long-Term Asthma Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Long-Term Asthma Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst